Skip to content
GLP-1 Savers
Menu
Ranked #369 · Watch List

Alinwell review

A women's GLP-1 program advertising semaglutide "from $149/mo" that its own checkout labels a first-month discount off $249, with a three-month plan that costs more per month than the price on the homepage.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $249/mo

Save ~82% vs brand-name

$249/mo month-to-month (charged every 30 days; $149 is the first month only)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. Every public surface advertises "from $149/mo" for semaglutide and "from $199/mo" for tirzepatide. Neither is a rate. The checkout labels those exact figures "$100 off first month" and strikes $249 and $299 beside them, so month two costs $100 more than the number that brought you in. The three-month plan then costs more per month than the advertised price — $219 against $149 — because it is being compared to a standing rate the marketing never shows. A fourth product, an oral GLP-1 at $150 a month, is live and buyable at the checkout with no page of its own and no place in the homepage grid. Neither the microdose nor the oral program names the molecule it contains, on any surface.

How much does Alinwell cost?

The price Alinwell publishes is $249/mo month-to-month (charged every 30 days; $149 is the first month only). Tirzepatide is listed at $299/mo month-to-month (charged every 30 days; $199 is the first month only). We flag this one to watch: confirm the ongoing rate with Alinwell before you count on it, because a low first month can step up afterward. That works out about 82% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$249/mo month-to-month (charged every 30 days; $149 is the first month only)
Tirzepatide
$299/mo month-to-month (charged every 30 days; $199 is the first month only)
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

The Value Score card

Alinwell scored on our six published factors. See the methodology.

Lowest Real Price67/100
No Teaser-Rate Bait24/100
Both Molecules98/100
Nationwide Availability72/100
Easy Cancellation58/100
Reputation60/100

Why it's a deal

  • The full ladder is visible at the checkout before payment: $249 and $299 standing, $219 and $269 on three months, $189 and $239 on six, plus $149 for the microdose and $150 for the oral program — a complete price list, even though the marketing shows only its cheapest corner
  • Four programs rather than two: full-dose semaglutide and tirzepatide, a low-dose injectable at $149 a month with no prepay tier attached, and an oral GLP-1 at $150
  • Certificates of analysis are published for the compounded batches and they name the compounders — Emerald Compounding Pharmacy in Tampa and Boudreaux's New Drug Store in Lake Charles, both with street addresses and one with a phone number
  • The certificates also disclose what is in the injection: both GLP-1s are compounded with glycine, a fact the product copy never mentions and the intake only asks about as an allergy
  • A real address and phone number are published on the contact page, and clinical hours are stated rather than implied

Read the fine print

  • The advertised price is an introductory price. "From $149/mo" is what the checkout calls "$100 off first month"; the standing rate is $249 for semaglutide and $299 for tirzepatide, so a reader budgeting from the homepage will be wrong by $1,200 a year
  • Because the advertised figure is an intro rate, the commitment plans look like a penalty: the plan marked most popular costs $219 a month against an advertised $149, and the six-month card strikes the three-month price rather than the monthly one
  • Three incompatible cancellation rules are published at once — 48 hours' notice in the terms, 30 days' notice in the treatment-page questions, and "cancel anytime, no contracts" on the checkout and the homepage banner. Which one governs is exactly what a reader needs to know
  • The terms and the privacy policy print an unedited template where the company's address belongs: "123 Example Street, Suite 100, Your City, WI, 92308", while the contact page gives a real Texas address. The legal pages a buyer would rely on were never filled in
  • No clinician, medical group, license number or identifier appears anywhere on the site, and neither the microdose nor the oral program says which molecule it contains
  • The checkout says "You're Approved" and runs a countdown reading "Approval expires in 14:56" before any clinician has seen the file — the next screen then explains that a physician reviews the information after payment
  • Patient counts and ratings disagree across the site: 10,000-plus, 1,743-plus and 7,200-plus patients on three surfaces, and five different average ratings. The review badge on the homepage points at a profile that does not exist, checked the same day against a known-good profile that did

The bottom line

Best for: Shoppers comparing month-two prices rather than signup prices, who want a low-dose or oral option in the same place and will read the checkout before agreeing to anything. A women's GLP-1 program advertising semaglutide "from $149/mo" that its own checkout labels a first-month discount off $249, with a three-month plan that costs more per month than the price on the homepage.

Ranked #369 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Alinwell, out of 417 others we track.

Shopping Alinwell against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Alinwell, and every program that undercuts or outscores it — starting with Nucore Health, the closest match on score — is ranked on the Alinwell alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Alinwell's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Alinwell's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals